Evidence on the Benefits and Harms of Screening and Treating Pregnant Women Who Are Asymptomatic for Bacterial Vaginosis: An Update Review. Figure 3

You Are Here: AHRQ Home > Clinical Information > U.S. Preventive Services Task Force > Topic Index > Screening for Bacterial Vaginosis in Pregnancy > Update Review

Figure 3. Study characteristics and absolute risk reduction of delivery before 37 weeks

Table displays characteristics of studies reviewed and absolute risk reduction of delivery before 37 weeks. For details, go to [D] Text Description.

[D] Select for Text Description.

Span = treatment timing spans less than 20 weeks and greater than 20 weeks.
*Baseline risk is the percentage of deliveries before 37 weeks in the placebo group. Absolute risk reduction is the difference in probability of delivery before 37 weeks (control minus treatment).
†McDonald et al.⁵⁸ and Carey et al.⁵⁷ performed a high-risk group subanalysis; high-risk group is included in total study population of the average-risk target group. Odendaal et al.⁵⁰ included 2 target populations; high-risk and low-risk groups are 2 separate groups.

Return to Document